Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Safety and Pharmacokinetics of a Single Dose of Linzagolix in Female Subjects With Normal and Impaired Renal Function

NCT03961932 is registered in ClinicalTrials.gov with ObsEva SA as lead sponsor.

NCT NCT03961932
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03961932 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Safety and Pharmacokinetics of a Single Dose of Linzagolix in Female Subjects With Normal and Impaired Renal Function
Lead sponsor
ObsEva SA
Phase
Phase 1
Overall status
Completed
Start date
May 15, 2019
Completion date
January 31, 2020
Enrollment
33 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

healthy participants, renal impairment